BioXcel Therapeutics raises $14M in registered direct offering with warrants

BioXcel Therapeutics, Inc.

Total gross proceeds of $14M from sale of 188,383 shares and pre-funded warrants for up to 3,811,617 shares.
Combined offering price: $3.50 per share + accompanying warrant; $3.499 per pre-funded warrant + accompanying warrant.
Warrants exercisable at $4.20 per share; option warrants to purchase up to 4,000,000 additional shares.
Placement agent Rodman & Renshaw receives a 6.0% cash fee on gross proceeds.
Closing expected on first Trading Day after March 3, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.